Meeting
2019 Genitourinary Cancers Symposium
Identification, incidence and clinical outcomes of patients (pts) with hypermutated prostate cancer (PC).
Authors
Simon Yuen Fai Fu
British Columbia Cancer Agency - Vancouver Centre, Vancouver, BC, Canada
Simon Yuen Fai Fu , Elie Ritch , Steven Yip , Daniel Khalaf , Sinja Taavitsainen , Matti Annala , Gillian Vandekerkhove , Igal Kushnir , Sebastien J. Hotte , Cristiano Ferrario , Alexander William Wyatt , Kim N. Chi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 195)
DOI
10.1200/JCO.2019.37.7_suppl.195
Abstract #
195
Poster Bd #
H16
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
SPOP mutations in prostate cancer: Clinical and genomic features.
First Author: Mari Nakazawa
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic, clinical characteristics, and treatment outcomes of patients with metastatic castration-sensitive prostate cancer with SPOP mutations: Analysis from the Kaiser Permanente Northern California Healthcare System.
First Author: Sachdev P. Thomas
Poster
2019 Genitourinary Cancers Symposium
EphB4-EphrinB2 receptor-ligand pair as a novel target in prostate cancer (PC).
First Author: Sarmad Sadeghi
Poster
2018 Genitourinary Cancers Symposium
Treatment patterns for metastatic hormone-sensitive prostate cancer (mHSPC) progressing after up-front docetaxel in combination with androgen deprivation therapy (D-ADT).
First Author: Pedro C. Barata